(Q30318252)

17 June 2017

Novel insights into the molecular mechanisms of HLA class I abnormalities (English)

1 reference

17 June 2017

1

Barbara Seliger

1 reference

17 June 2017

27 November 2011

1 reference

Cancer Immunology, Immunotherapy

17 June 2017

1 reference

17 June 2017

61

1 reference

17 June 2017

2

1 reference

17 June 2017

249-254

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-011-1153-9

17 June 2017

0 references

cites work

Myeloid-derived suppressor cells in human cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

The peptide-loading complex--antigen translocation and MHC class I loading.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Molecular mechanisms of MHC class I abnormalities and APM components in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible "hard" lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Identification of human cancers deficient in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Distinct molecular mechanisms leading to deficient expression of ER-resident aminopeptidases in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

A single-nucleotide deletion leads to rapid degradation of TAP-1 mRNA in a melanoma cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

A rare transporter associated with antigen processing polymorphism overpresented in HLAlow colon cancer reveals the functional significance of the signature domain in antigen processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

The mutation in the ATP-binding region of JAK1, identified in human uterine leiomyosarcomas, results in defective interferon-gamma inducibility of TAP1 and LMP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Defective human leukocyte antigen class I-associated antigen presentation caused by a novel beta2-microglobulin loss-of-function in melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: β2‐microglobulin inactivation in MSI‐positive tumors and LMP7/TAP2 downregulation in MSI‐negative tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Induction of immunogenicity of a human renal-cell carcinoma cell line by TAP1-gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Varicellovirus UL 49.5 proteins differentially affect the function of the transporter associated with antigen processing, TAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Herpesviruses and immunity: the art of evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Epigenetic control of the immune escape mechanisms in malignant carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Down-regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Differential expression of tapasin and immunoproteasome subunits in adenovirus type 5- versus type 12-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

T cell recognition of HLA-A2 restricted tumor antigens is impaired by the oncogene HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Proto-oncogene PML controls genes devoted to MHC class I antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

Identification of E2F1 as an important transcription factor for the regulation of tapasin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1153-9

10.1007/S00262-011-1153-9

21 January 2018

Identifiers

DOI

1 reference

PubMed ID

22120755

Dimensions Publication ID

17 June 2017

0 references

1 reference

PubMed ID

22120755